Skip to main content

Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey

Abstract

Background

The two major causes of cancer-related deaths among women in Ghana are breast cancer (BC) and cervical cancer (CC). These types of cancers typically do not show any symptoms until they have progressed. Therefore, it is important to screen for early detection. This research aimed to investigate the rate of breast cancer and cervical cancer screening, as well as the factors associated with it, among women of reproductive age in Ghana.

Methods

This study analysed data from the 2022 Ghana Demographic and Health Survey. A total of 15,014 women aged 15 to 49 years were included in the analysis. Descriptive statistics and binary logistic regression were employed to analyse the data with the aid of STATA/SE, version 17.

Results

It was found that 18.4% and 5.0% of the women had screened for BC and CC, respectively. Women aged 45–49 years were about three times more likely (aOR = 2.83, 95% CI: 1.88–4.24) to screen for BC compared to those aged 15–19 years. Women who had tested for HIV had increased odds (aOR = 1.88, 95% CI: 1.56–2.25) of screening for BC compared to their counterparts. Women within the richest wealth index (aOR = 1.95, 95% CI: 1.40–2.72) had increased odds of screening for BC compared to those in the poorest wealth index. Regarding CC screening, women with higher education (aOR = 2.56, 95% CI: 1.53–4.29) were two times more likely to screen for CC compared to those with no formal education. Women who did not use tobacco (aOR = 0.45, 95% CI: 0.21–0.96) had decreased odds of CC screening compared to their counterparts.

Conclusions

This study showed that the uptake of BC and CC screening services among women in Ghana was very low. The drivers of BC and CC screening included enabling, predisposing, and need factors. Stakeholders can leverage the mass media to raise awareness and educate women in reproductive age about the importance of BC and CC screening. This study provides relevant information that can inform BC and CC policies and programmes in Ghana.

Peer Review reports

Introduction

Breast cancer (BC) and cervical cancer (CC) remain global public health concerns [1]. BC is the most common cancer among women [2], and CC is the fourth most common cancer among women worldwide [3]. BC and CC contribute to disability-adjusted life years (DALY) and premature death [4]. Globally, 17.4 million and 8.1 million cases of BC and CC, respectively, were reported in 2017 [4,5,6]. Approximately 2.3 million new BC cases and 685,000 BC-related deaths were recorded globally in 2020 [7]. Additionally, 604,127 new CC cases and 341,831 CC-related deaths were reported in the same year across the world [3, 5]. In Africa, 198,553 (29.29%) BC cases with 91,252 (21.9%) deaths, and 80,614 (18.5%) CC cases with 125,699 (18.5%) deaths were reported in 2022 [8].

The burden of BC and CC in Africa continues to increase due to the ageing population, low socioeconomic status and environmental challenges [4, 9, 10]. The burden of breast cancer (BC) is higher in West African countries compared to other African regions [8]. For example, a study found that West Africa had the second-highest incidence of breast cancer (37.3 per 100,000) compared to Southern (46.2 per 100,000), Eastern (29.9 per 100,000), and Central Africa (27.9 per 100,000). Also, West Africa had the highest breast cancer mortality rate (17.8) compared to Southern (15.6), Central (15.8), and Eastern (15.4) Africa [11].

In Ghana, the incidence of BC increased from 23.8 per 100,000 in 2008 to 37.8 per 100,000 in 2018 [12]. In 2020, 4,645 (20.4%) new BC cases were recorded in the country, which is more than twice the number of cases reported in 2012 (2,240), with close to 50.0% case fatality rate [13]. BC accounts for 12.4% of all cancer deaths among women in Ghana [14]. Additionally, the incidence of CC in Ghana is 35.4%, which is above the Sustainable Development Goal (SDG) 3.4 target of below 4 per 100, 000 women [12, 15].

The increasing cases of breast cancer and cervical cancer in Ghana can be linked to demographic shifts and lifestyle changes, along with a higher prevalence of risk factors such as obesity and reproductive behaviours, similar to the situation in other African countries [16]. For instance, the female population in Ghana accounts for over 50.0% of the total population [17]. In the years spanning from 1960 to 2021, Ghana’s population has increased by five folds, surging from 6.7 million to 30.8 million [17]. Furthermore, there are indications that the percentage of elderly individuals in the nation is rising [18]. The prevalence of overweight and obese women has risen significantly. A recent Demographic and Health Survey found that over 50.0% of Ghanaian women between 20 and 49 years old were overweight or obese [19]. Regarding genetic factors, research into pathogenic mutations has shown that high to moderate-risk breast cancer genes are consistent among various populations, such as African, Asian, and European populations [20].

Screening for BC and CC is crucial for early detection and can help reduce DALYs and mortality [3]. In developing countries, breast cancer is typically detected through breast self-examination (BSE), clinical breast examination (CBE), and mammography [21]. Meanwhile, cervical cancer is screened using methods such as visual inspection, human papillomavirus (HPV) testing, and cytology [22]. In Ghana, breast cancer examination could involve a clinical breast examination or a mammogram. As for cervical cancer, screening may include a Pap smear or HPV test, as well as visual inspection with acetic acid (VIA), where a healthcare provider applies vinegar to the cervix to observe any potential reactions [19]. Despite the benefits associated with BC and CC screening, there is a low uptake of screening services among women in African countries [4, 23,24,25]. For instance, a survey in four sub-Saharan African countries revealed an overall prevalence of 13.0% for BC screening [26]. Regarding the uptake of CC screening services, national-level surveys in Kenya, Cameroon, Namibia, and Zimbabwe revealed a prevalence of 23.4% [27].

There are several factors associated with the uptake of BC and CC screening services. These include age, level of knowledge about the importance of screening, desire for early detection, perceived risk, religion and emotional support. Other associated factors include culture, spousal and family support, previous engagement with screening programmes, information gathered from people diagnosed with cancer, proximity of screening centres, cost of screening, privacy and confidentiality [4, 28]. Studies have also found that provider sex, quality of care, method of disclosure, waiting time, and follow-up schedule were associated with the uptake BC and CC screening services [4, 23].

There is a paucity of data on the national prevalence and drivers of BC and CC screening among women of reproductive age in Ghana. This is the first study in the country to examine BC and CC screening among women of reproductive age using nationally representative data. The findings from this study can inform national-level BC and CC screening and treatment policies and programmes. Therefore, this study aimed to identify the proportion of women of reproductive age who have screened for BC and CC. This study also sought to assess factors associated with the uptake of BC and CC screening services among Ghanaian women. We analysed data from the recent Ghana Demographic and Health Survey (2022 GDHS).

This study was underpinned by Andersen Health Service Utilization Model. This model emphasizes predisposing, enabling and need factors that influence health service utilization [29]. Predisposing factors comprise demographic and social characteristics of individuals, including age, educational status, and health behaviours such as smoking. Enabling factors refer to factors that enable or impede use, including personal or community resources that make it possible for people to access healthcare. Examples include socio-economic status, health insurance coverage and transportation issues. Need factors refer to how the individual views their health status and wellbeing or professional assessment of an individual's health status [29].

Methods

Data source

This study analysed secondary data from the 2022 Ghana Demographic and Health Survey. This survey was conducted by the Ghana Statistical Service and funded by the United States Agency for International Development and the United States President’s Malaria initiative. The 2022 GDHS collected data on demographic and health indicators, including age, educational status, wealth status, contraceptive use, breast and cervical cancer screening.

Population and sampling

The target population for the 2022 GDHS included women of reproductive age (15–49 years) across the 16 administrative regions in Ghana. The sampling frame from the 2021 Population and Housing Census was used. A stratified two-stage cluster sampling process was employed for urban and rural areas. In stage one, 618 clusters were selected from the sampling frame using probability proportionate to size. In stage two, household listing and mapping were carried out in all selected clusters to obtain a list of households. The list was then used as a sampling frame for the selection of households. For the 2022 GDHS, a national stratified representative sample of 18,450 households were selected from 618 clusters. All women who had spent the night before the survey in the selected households were eligible for the survey. A total of 15,014 women of reproductive age were interviewed. This study analysed data from all the 15,014 women (weighted).

Study variables

Outcome variables

The outcome variables were BC and CC screening by a health care provider, which was originally coded as ‘1 = Yes, 2 = No and 8 = don’t know. These variables were recoded into a dummy variable as ‘1 = Yes, and 0 = otherwise’.

Independent variables

The independent variables were categorized into predisposing, enabling and need factors. The predisposing factors included age of the respondent, educational status, marital status, parity, and age at menarche, age at first sexual intercourse, tobacco use, contraceptive use and abortion. Enabling factors included wealth index, health insurance, employment status, type of place of residence, region, frequency of reading newspaper, listening to radio and watching television, barriers to care (distance, money, permission and not wanting to go alone) and traveling time to the nearest health facility. Self-reported health status, health facility visits, STI status and HIV testing constituted need factors.

Data analysis

We employed descriptive statistics, including frequency and percentage, and binary logistic regression to analyse the data. Two models were computed, including model 1 (drivers of BC screening, both crude and adjusted odd ratios) and model 2 (drivers of CC screening, both crude and adjusted odd ratios). We used STATA/SE, version 17 to aid the data analysis. The ‘svyset’ function in STATA was used to adjust for the sampling weight, clustering and stratification. The results were reported at a 95% confidence interval and a significance level of 0.05.

Ethical consideration

The 2022 GDHS protocol was approved by the Ghana Health Service Ethics Review Committee and ICF Institutional Review Board. In this study, ethical approval was not required since further analysis of the 2022 GDHS data was performed. We downloaded the dataset from the website of the DHS Program after seeking permission.

Results

Participant characteristics

The results showed that 17.9% of the participants were adolescent girls. Approximately 60.0% of the participants had secondary education and 40.0% of them were married. 32.3% of the participants were nulliparous, and 22.3% of them were in the richest wealth index. In addition, a majority (74.6%) of the participants were working, 57.0% resided in urban areas, and approximately 20.0% resided in the Ashanti region.

Regarding exposure to mass media, 88.5% of the participants did not read a newspaper, 33.3% did not listen to radio, and 70.0% were exposed to television. About 90.0% of the participants were covered by health insurance, and 31.2% perceived their health status to be very good. For a majority of the participants, distance to the health facility (77.7%), obtaining money for treatment (55.3%), and obtaining permission for treatment (90.1%) were not problems to accessing care. Specifically, 12.4% of the participants had to travel for sixty or more minutes to the nearest health facility.

In addition, 48.1% of the participants had not visited a health facility in the last 12 months, 5.5% had a sexually transmitted infection in the last 12 months, and 42.6% had not tested for HIV. Additionally, 3.7% of the participants experienced early menarche, 10.3% initiated early sexual intercourse, 23.4% used modern contraceptives, 25.3% terminated a pregnancy, and 1.0% used cigarettes or tobacco. Exactly, 18.4% and 5.0% of the participants had screened for breast cancer and cervical cancer, respectively (Table 1).

Table 1 Descriptive statistics of participant characteristics

A crude analysis of factors associated with BC and CC screening among women of reproductive age in Ghana

At the crude analysis level, uptake of CC screening service was significantly associated with predisposing factors, such as respondent’s age, educational status, marital status, parity, and age at menarche, age at first sexual intercourse, contraceptive use and history of abortion. For instance, participants who had terminated a pregnancy (cOR = 1.47, 95% CI: 1.29–1.68) had increased odds of BC screening compared to their counterparts. Additionally, participants who use modern method of contraception (cOR = 1.29, 95% CI: 1.12–1.49) were more likely to screen for BC compared to those using no contraception.

We also found a significant association between enabling factors (wealth index, health insurance, currently working, region, place of residence, exposure to mass media, and barriers to accessing care) and the uptake of breast cancer screening service. For example, participants with health insurance (cOR = 2.22, 95% CI: 1.71–2.88) were two times more likely to screen for BC compared to their counterparts. The odds of BC screening decreased with traveling time to the nearest health facility. Participants who had to travel for less than ten minutes (cOR = 2.33, 95% CI: 1.79–3.03) to the nearest health facility had increased odds of BC screening compared to those who had to travel for an hour or more.

The associations between need factors, such as health status, health facility visit, having STI, testing for HIV and testing for cervical cancer, and uptake of BC screening services were found to be statistically significant. For instance, participants who had visited a health facility in the last 12 months (cOR = 2.06, 95% CI: 1.82–2.33) had increased odds of BC screening compared to their counterparts. Additionally, participants who had tested for HIV (cOR = 3.38, 95% CI: 2.95–3.87) and cervical cancer (cOR = 11.16, 95% CI: 8.95–13.90) had increased odds of BC screening compared to their counterparts (Table 2).

Table 2 Crude binary logistic regression for predictors of the uptake of BC and CC screening services

In addition, there was a significant association between predisposing factors and CC screening. For instance, respondent’s age, educational status, marital status, parity, age at first sexual intercourse, tobacco use, contraceptive use and pregnancy termination were significantly associated with CC screening. For instance, participants who had terminated a pregnancy (cOR = 1.60, 95% CI: 1.28–1.98) had increased odds of CC screening compared to their counterparts.

The following enabling factors were associated with CC screening: wealth index, health insurance, working status, region, place of residence, exposure to mass media and barriers to accessing healthcare. For example, participants residing in rural areas (cOR = 0.43, 95% CI: 0.33–0.57) had lower odds of CC screening compared to those residing in urban areas. Additionally, participants who did not have a problem with getting money for treatment (cOR = 1.66, 95% CI: 1.34–2.06) had increased odds of CC screening compared to their counterparts.

Moreover, need factors, such as health status, health facility visits, HIV testing and BC screening, were associated with CC screening. For instance, participants who had poor health status (cOR = 0.45, 95% CI: 0.23–0.85) had decreased odds of CC screening compared to those who had very good health status. Additionally, participants who had tested for HIV (cOR = 4.78, 95% CI: 3.42–6.69) were four times more likely to test for CC (Table 2).

An adjusted analysis of factors associated with BC and CC screening among women of reproductive age in Ghana

In the adjusted analysis, the results showed that the uptake of BC screening service was driven by predisposing, enabling and need factors. Predisposing factors, such as age, education and contraceptive use were significantly associated with the uptake of BC screening service. For instance, participants aged 45–49 years (aOR = 2.83, 95% CI: 1.88–4.24) were more likely to screen for BC compared to adolescent girls. Additionally, participants with a higher educational status (aOR = 3.76, 95% CI: 2.75–5.15) were more likely to screen for BC compared to those with no formal education. Moreover, participants who used modern methods of contraception (aOR = 1.16, 95% CI: 1.00–1.36) had increased odds of BC screening compared to participants who use no contraceptive.

In addition, enabling factors, including wealth index, place of residence, region, health insurance, frequency of reading newspaper, frequency of listening to radio, and barriers to accessing care, were associated with the uptake of BC screening services. Participants within the richest wealth index (aOR = 1.95, 95% CI: 1.40–2.72) were more likely to have their breast examined for BC by a health provider compared to those within the poorest wealth index. Additionally, participants in rural areas (aOR = 0.81, 95% CI: 0.67–0.99) had lower odds of BC screening compared to those in urban areas. Furthermore, participants who had health insurance (aOR = 1.41, 95% CI: 1.10–1.80) were more likely to screen for BC compared to their counterparts.

It was also found that need factors, such as health facility visit, testing for HIV and testing for cervical cancer were associated with the uptake of BC screening service. For example, women who had visited a health facility in the last 12 months (aOR = 1.42, 95% CI: 1.23–1.65) had increased odds of BC screening compared to their counterparts. In addition, participants who had tested for HIV (aOR = 1.88, 95% CI: 1.56–2.25) and cervical cancer (aOR = 6.46, 95% CI: 5.05–8.26) had increased odds of BC screening compared to their counterparts (Table 3).

Table 3 Adjusted binary logistic regression for predictors of uptake of BC and CC screening

The uptake of cervical cancer screening service was driven by predisposing factors, including age, education, marital status, age at first sexual intercourse and tobacco use. For instance, participants aged 45–49 years (aOR = 2.72, 95% CI: 1.27–5.80) were two times more likely to screen for CC compared to adolescent girls. Additionally, women who initiated early sexual intercourse (aOR = 5.76, 95% CI: 2.22–14-96) were five times more likely to screen for CC compared to those who never had sex. Participants who did not use tobacco (aOR = 0.45, 95% CI: 0.21–0.96) had decreased odds of CC screening compared to tobacco users.

In addition, we found a significant association between enabling factors, such as wealth index and region, and CC screening. Women within the richest wealth index (aOR = 2.07, 95% CI: 1.17–3.66) had increased odds of CC screening compared to those within the poorest wealth index. Moreover, participants in the Northern region (aOR = 2.87, 95% CI: 1.59–5.16) were more likely to screen for CC compared to those in the Greater Accra region.

The only need factor significantly associated with CC screening was screening for breast cancer. Women who had screened for breast cancer (aOR = 6.82, 95% CI: 5.42–8.58) were six times more likely to screen for cervical cancer compared to their counterparts (Table 3).

Discussion

This study sought to assess the prevalence and drivers of BC and CC screening among women of reproductive age in Ghana using Andersen’s healthcare utilization model as a theoretical guide. In this study, the prevalence of BC screening was 18.4%. Our finding is greater than that of a national population-based study conducted in Lesotho, where 9.7% of women of reproductive age had undergone BC screening [30]. Another study among four sub-Saharan African countries revealed an overall prevalence of 12.9% for BC screening [26]. The results of this study highlight the possible clinical and public health ramifications because early detection is crucial for the management and prevention of breast cancer. Therefore, the low prevalence of BC screening among women of reproductive age in Ghana underscores the need for stakeholders to intensify public health education to help raise awareness of breast cancer and promote the uptake of screening services.

The prevalence of CC screening was 5.0%. A constant screening prevalence of 14.0% was observed for the African sub region from 2000 to 2020 [31]. Another study on CC screening revealed that 9.0% of women from low-middle-income countries, 4.3% from SSA, and 3.0% from Ghana had screened for CC [32]. A study using national-level data in Kenya, Cameroon, Namibia, and Zimbabwe found a prevalence of 23.4% for CC screening [27] and 13.1% in Malawi [33]. Although the uptake of both BC and CC appears to be increasing, the rate is still low. A possible explanation is the non-inclusion of clinical screening for the breast and cervix in the National Health Insurance benefit package. Additionally, most sub-Saharan African countries lack national-level policies for promoting these services among women [34]. In addition, approximately one-third of respondents answered that they had moderate to very poor health status, which could signify low access to healthcare in terms of distance from health facility [34], cost [27], or availability of trained health personnel for such examinations [35, 36]. Therefore, prioritizing and including clinical examinations for these two cancers in health insurance plans could increase the use of screening services, especially among women in poor wealth quintiles.

Predisposing, enabling, and need factors for breast and cervical cancer screening

Our findings revealed that women aged 20 years and above had higher odds of screening for BC and those aged 40 years and above had increased odds of screening for CC. Similarly, a study in four African countries (Kenya, Cameroon, Namibia, and Zimbabwe) revealed that women aged 40 years and above were twice more likely to be screened for CC than those below 40 years [27]. However, this finding contradicts a finding of a study in Namibia where women aged 35–44 years were more likely to screen for CC compared to those aged 45 years and older [33]. For BC, a study in Lesotho revealed an increase in screening uptake among those aged 20–24 years (10.82%) and 30–34 years (11.32%); thereafter, it declined among those aged 35–39 years (10.47%) and 40–44 years (9.5%) [30]. In another study in Africa, BC screening was less common among participants aged 15–24 years (7.6%) compared to those aged 35–49 years (17.2%) [26]. This result also confirms earlier research in Burkina Faso [37], Kenya [38], and South Africa [39].

The contexts in which these studies were performed could be a possible factor for these observations. Additionally, the timing of interventions on health promotion activities on the uptake of such services might vary in the various study settings. This result could be attributed to the fact that awareness initiatives on screening for cervical and breast cancers and its benefits have been targeted at older women compared to younger women, resulting in a greater likelihood of screening among older women [36]. On the basis of emerging evidence, cervical and breast cancers are being diagnosed at younger ages [40]. In this light, it is prudent to target people of all ages in cancer screening and awareness programs.

In addition, the likelihood of BC and CC screening was higher among women with higher education. A multi-country study using DHS data from Burkina Faso, Ivory Coast, Kenya and Namibia [26] and a national population-based study in Lesotho [30] reported similar findings with regards to BC screening. Similar findings have been reported in Kenya, Cameroon, Namibia, and Zimbabwe [27]; Benin, Ivory Coast, Kenya, 40.0%, and Zimbabwe [26]; and South Africa [41]. This finding supports the existing evidence on determinants of utilization of cancer screening services. Educated women could be more informed about the importance of screening for such cancers than those who are not educated.

Our findings contradict with those of a recent study in India, where women who were married had slightly greater odds of screening for CC compared to those who were previously married [42]. However, our findings are similar to another study in peri-urban Ghana, which reported greater odds of CC screening among women who were married or divorced compared to those who were cohabiting [43]. This could be due to exposure to human papillomavirus, which usually occurs in sexually active women [44].

Enabling and needs factors associated with breast cancer and cervical cancer screening among women of reproductive age

In this study, the odds of screening for BC were higher among women within the richest wealth index. In a multi-country study including Albania, Tajikistan, Namibia, and Kenya, the prevalence of BC screening was found to be higher among participants in the highest wealth quintile [45]. Similar trends were recorded by studies in Botswana [46] and India [47]. Regarding CC screening, the same trend was observed among women in the richest wealth index. This confirms the findings of studies in India [42], Malawi [48] and Botswana [46], where increasing wealth status of women positively influenced the uptake of CC screening service. Various studies have found an association between low socioeconomic status to poor knowledge [46, 49] and less access to cancer screening services [50,51,52]. Hence, socioeconomic empowerment of women could help increase the uptake of cancer screening services [53].

Furthermore, our findings revealed that screening for BC was associated with place of residence, reading newspapers, listening to radio and being covered by health insurance. Whereas a study in Rwanda revealed that living in urban areas increased the likelihood of cervical cancer screening by more than three times [54], another study from India revealed a slightly lower prevalence among rural inhabitants than among those in urban areas [42]. Our observation of media influence is consistent with earlier studies in which women who read newspapers were more likely to screen for cancer [36, 55]. This finding suggests that mass media can be used as tool for promoting cancer screening among women in both rural and urban locations. The findings also revealed that women covered by health insurance had greater chances of BC screening. Studies in the United States [5, 56] and Burkina Faso, Ivory Coast, Kenya and Namibia [26] recorded higher BC screening uptake among the insured. These findings underscore the need to enrol more women in the national health insurance scheme. Poor treatment outcomes for BC [57] have been found among women without health insurance coverage. Subscribing to health insurance has the potential to increase the demand for breast cancer screening services among low-income populations [56, 57]. Additionally, our findings revealed that screening for CC was associated with the uptake of BC screening service and vice versa. This observation is consistent with an earlier study in Ghana where CC screening was significantly linked to BC screening among adult women [28]. Women who had screened for CC might be knowledgeable about the importance of CC screening and vice versa or they were advised by health care providers to screen for both CC and BC.

Recommendations

The insights from this study highlight the gaps in public health interventions aimed at fighting non-communicable diseases such as cancer. Considering that a considerable number of the women were adolescents, had no formal education, widowed and belonged to the poor and poorer wealth quintiles, the burden of these cancers could be curtailed by prioritizing the needs of these vulnerable groups. Media exposure was a driver of the uptake of screening services. Hence, promoting health education through the mass media could help increase the uptake of cancer screening services. As per the guidelines of the National Comprehensive Cancer Network (NCCN), American Society for Clinical Oncology (ASCO), and European Society for Medical Oncology (ESMO), we recommend that women aged 25 and below undergo risk assessment and screening for cervical cancer and breast cancer to minimize the risk and promote early detection of cancer. Also, stakeholders, such as the Ghana Health Service, should encourage regular mammography screening for women at average risk of breast cancer (aged 45 and above) and periodic human papillomavirus testing for women at risk of cervical cancer (aged 25 to 65 years).

Strengths and limitations of the study

Notwithstanding the rigour of the study design, recall bias could influence the results of this study. Additionally, relying on self-reporting could result in social desirability bias. The variables included in this study were limited to the variables available in the GDHS dataset. Nonetheless, the use of nationally representative data, standardized instruments for data collection and training of field workers improved the validity and reliability of the findings.

Conclusion

Our study revealed that the prevalence of both BC and CC screening among women of reproductive age was low. Women who lived in rural areas, not educated, uninsured, and of low socio-economic status were less likely to screen for BC and CC. Going forward, it is crucial for stakeholders to prioritize the uptake of BC and CC screening services. Moreover, stakeholders could leverage the mass media to raise awareness and promote early detection of BC and CC among women of reproductive age in Ghana.

Availability of data and materials

The DHS Program owns the data used in this study, therefore, the authors cannot share the data. Interested persons can contact The DHS Program for the data (https://dhsprogram.com/data/available‑datasets.cfm). The authors confirm they had no special access or privileges to the data that other researchers would not have.

Abbreviations

BC:

Breast Cancer

CC:

Cervical Cancer

GAEC:

Ghana Atomic Energy Commission

GDHS:

Ghana Demographic Health Survey

SDG:

Sustainable Development Goal

WHO:

World Health Organization

WRA:

Women in Reproductive Age

NCCN:

National Comprehensive Cancer Network

ASCO:

American Society for Clinical Oncology

ESMO:

European Society for Medical Oncology

SSA:

Sub-Saharan Africa

References

  1. Xu Y, Gong M, Wang Y, Yang Y, Liu S, Zeng Q. Global trends and forecasts of breast cancer incidence and deaths. Scientific Data. 2023;10(1):334.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers. 2021;13(17):4287-317.

  3. WHO. Breast Cancer and Cervical Cancer -Health Topics Facts Sheets, download on 19th January, 2024. 2023.

    Google Scholar 

  4. Akoto EJ, Allsop MJ. Factors Influencing the Experience of Breast and Cervical Cancer Screening Among Women in Low-and Middle-Income Countries: A Systematic Review. JCO Global Oncology. 2023;9:e2200359.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zhao M, Wu Q, Hao Y, Hu J, Gao Y, Zhou S, Han L. Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007–2017: findings from the Global Burden of Disease Study 2017. BMC Womens Health. 2021;21(1):419.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Liu J, Wang J: Disability-adjusted life-years (DALYs) for breast cancer and risk factors in 195 countries: findings from Global Burden of Disease Study 2017. medRxiv. 2020:2020.2004. 2002.20050534.

  7. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article  PubMed  Google Scholar 

  8. GLOBOCAN: GLOBOCAN 2020: New Global Cancer Data. IARC Globocan 2022 with new estimates on the global cancer burden. 2022.

  9. GLOBOCAN: GLOBOCAN 2020: New Global Cancer Data. IARC released on 14th December the updated Globocan 2020 with new estimates on the global cancer burden, indicating that it has risen to 19.3 million cases and 10 million cancer deaths in 2020. 2020:220–229.

  10. Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze AJTL. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847–60.

    Article  Google Scholar 

  11. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  PubMed  Google Scholar 

  12. GAEC: The Ghana Health Service (GHS) is drafting a cervical cancer strategy to support national efforts at prevention and control-Ghana’s Cervical Cancer Prevalence Highest in The Subregion. Ghana Atomic Energy Commission (GAEC), Office of Cooperate and Public Affairs, GAEC Retrived on 22–01–24 2020.

  13. Laryea DO, Awuah B, Amoako YA, Osei-Bonsu E, Dogbe J, Larsen-Reindorf R, Ansong D, Yeboah-Awudzi K, Oppong JK, Konney TO, et al. Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer. 2014;14:362.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mensah KB, Mensah ABB. Cancer control in Ghana: A narrative review in global context. Heliyon. 2020;6(8):e04564.

    Article  PubMed  PubMed Central  Google Scholar 

  15. WHO. Accelerating the elimination of cervical cancer as a global public health problem. 2019.

    Google Scholar 

  16. Jemal A, Bray F, Forman D, O’Brien M, Ferlay J, Center M, Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118(18):4372–84.

    Article  PubMed  Google Scholar 

  17. Ghana Statistical Service: Ghana 2021 Population and Housing Census. General report, volume 3A. Population of regions and districts In., vol. 3A. Ghana: Ghana Statistical Service 2021.

  18. Kpessa-Whyte M. Aging and demographic transition in Ghana: State of the elderly and emerging issues. Gerontologist. 2018;58(3):403–8.

    Article  PubMed  Google Scholar 

  19. Ghana Statistical Service (GSS) and ICF.: Ghana Demographic and Health Survey 2022. In. Accra, Ghana, and Rockville, Maryland, USA: GSS and ICF; 2024.

  20. Ahearn TU, Choudhury PP, Derkach A, Wiafe-Addai B, Awuah B, Yarney J, Edusei L, Titiloye N, Adjei E, Vanderpuye V. Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations. Cancer Epidemiol Biomark Prev. 2022;31(8):1593–601.

    Article  CAS  Google Scholar 

  21. da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics. 2017;72(4):244–53.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. World journal of clinical oncology. 2015;6(6):281.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Nyaaba JA, Akurugu E. Knowledge, barriers and uptake towards Cervical Cancer screening among female health workers in Ghana: A perspective of the Health Belief Model. International Journal of Africa Nursing Sciences. 2023;19:100587.

    Article  Google Scholar 

  24. Adanu R, Seffah J, Duda R, Darko R, Hill A, Anarfi J. Clinic visits and cervical cancer screening in Accra. Ghana Med J. 2010;44(2). https://doi.org/10.4314/gmj.v44i2.68885.

  25. Enyan NIE, Davies AE, Opoku-Danso R, Annor F, Obiri-Yeboah D. Correlates of cervical cancer screening participation, intention and self-efficacy among Muslim women in southern Ghana. BMC Womens Health. 2022;22(1):1–11.

    Article  Google Scholar 

  26. Ba DM, Ssentongo P, Agbese E, Yang Y, Cisse R, Diakite B, Traore CB, Kamate B, Kassogue Y, Dolo G. Prevalence and determinants of breast cancer screening in four sub-Saharan African countries: a population-based study. BMJ Open. 2020;10(10):e039464.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Alie MS, Negesse Y, Ayenew M. Determinants of Cervical Cancer Screening Among Women Aged 30–49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis. Cancer Control. 2023;30:10732748231195680.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Agyemang AF, Tei-Muno AN, Dzomeku VM, Nakua EK, Duodu PA, Duah HO, Bentil AB, Agbadi P. The prevalence and predictive factors of breast cancer screening among older Ghanaian women. Heliyon. 2020;6(4):e03838.

  29. Babitsch B, Gohl D. Von Lengerke TJGP-S-M: Re-revisiting Andersen’s Behavioral Model of Health Services Use: a systematic review of studies from. 2012;1998–2011:9.

    Google Scholar 

  30. Afaya A, Laari TT, Seidu AA, Afaya RA, Daniels-Donkor SS, Yakong VN, Ahinkorah BO. Factors associated with the uptake of clinical breast examination among women of reproductive age in Lesotho: analysis of a national survey. BMC Cancer. 2023;23(1):114.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yang L, Boily M-C, Rönn MM, Obiri-Yeboah D, Morhason-Bello I, Meda N, Lompo O, Mayaud P, Pickles M, Brisson M. Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000–2020). PLoS Med. 2023;20(1):e1004143.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, Poljak M, Murillo R, Broutet N, Riley LM. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10(8):e1115–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Mpachika-Mfipa F, Kululanga LI, Mfipa D, Kazembe A. Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study. BMC Womens Health. 2023;23(1):334.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Addo IY, Acquah E, Ayebeng C, Dickson KS. Influence of distance to health facilities on clinical breast cancer screening behaviour among women in five sub-Saharan African countries. BMC Public Health. 2023;23(1):915.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Seidu A-A, Darteh EKM, Agbaglo E, Dadzie LK, Ahinkorah BO, Ameyaw EK, Tetteh JK, Baatiema L, Yaya S. Barriers to accessing healthcare among women in Ghana: a multilevel modelling. BMC Public Health. 2020;20:1–12.

    Article  Google Scholar 

  36. Dickson KS, Boateng EN, Acquah E, Ayebeng C, Addo IY. Screening for cervical cancer among women in five countries in sub-saharan Africa: analysis of the role played by distance to health facility and socio-demographic factors. BMC Health Serv Res. 2023;23(1):61.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Compaore S, Ouedraogo CM, Koanda S, Haynatzki G, Chamberlain RM, Soliman AS. Barriers to cervical cancer screening in Burkina Faso: needs for patient and professional education. J Cancer Educ. 2016;31:760–6.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Tiruneh FN, Chuang K-Y, Ntenda PAM, Chuang Y-C. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey. BMC Womens Health. 2017;17:1–14.

    Article  Google Scholar 

  39. Phaswana-Mafuya N, Peltzer K. Breast and cervical cancer screening prevalence and associated factors among women in the South African general population. Asian Pacific journal of cancer prevention: APJCP. 2018;19(6):1465.

    PubMed  PubMed Central  Google Scholar 

  40. Fontham ET, Wolf AM, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YCT, Walter LC. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321–46.

    Article  PubMed  Google Scholar 

  41. Akokuwebe ME, Idemudia ES, Lekulo AM, Motlogeloa OW. Determinants and levels of cervical Cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa Demographic and health survey data, 2016. BMC Public Health. 2021;21(1):2013.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Muthuramalingam M, Muraleedharan V. Patterns in the prevalence and wealth-based inequality of cervical cancer screening in India. BMC Womens Health. 2023;23(1):337.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Tawiah A, Konney TO, Dassah ET, Visser LE, Amo-Antwi K, Appiah-Kubi A, Bell SG, Johnston C, Lawrence ER. Determinants of cervical cancer screening uptake among women with access to free screening: a community-based study in peri-urban Ghana. Int J Obstet Gynecol. 2022;159(2):513–21.

    Article  CAS  Google Scholar 

  44. Bowden SJ, Doulgeraki T, Bouras E, Markozannes G, Athanasiou A, Grout-Smith H, Kechagias KS, Ellis LB, Zuber V, Chadeau-Hyam M. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC Med. 2023;21(1):274.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Mahumud RA, Alam K, Keramat SA, Renzaho AM, Hossain MG, Haque R, Ormsby GM, Dunn J, Gow J. Wealth stratified inequalities in service utilisation of breast cancer screening across the geographical regions: a pooled decomposition analysis. Archives of Public Health. 2020;78:1–12.

    Article  Google Scholar 

  46. Keetile M, Ndlovu K, Letamo G, Disang M, Yaya S, Navaneetham K. Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15–64 years in Botswana. PLoS ONE. 2021;16(8):e0255581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Negi J, Nambiar D. Intersectional social-economic inequalities in breast cancer screening in India: analysis of the National Family Health Survey. BMC Womens Health. 2021;21:1–9.

    Article  Google Scholar 

  48. Chirwa GC. Explaining socioeconomic inequality in cervical cancer screening uptake in Malawi. BMC Public Health. 2022;22(1):1376.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Svendsen MT, Bak CK, Sørensen K, Pelikan J, Riddersholm SJ, Skals RK, Mortensen RN, Maindal HT, Bøggild H. Nielsen GJBph: Associations of health literacy with socioeconomic position, health risk behavior, and health status: a large national population-based survey among Danish adults. BMC Public Health. 2020;20:1–12.

    Article  Google Scholar 

  50. Narcisse M-R, Shah SK, Hallgren E, Felix HC, Schootman M, McElfish PA. Factors associated with breast cancer screening services use among women in the United States: An application of the Andersen’s Behavioral Model of Health Services Use. Prev Med. 2023;173:107545.

    Article  PubMed  Google Scholar 

  51. Shah SK, Nakagawa M. Lieblong BJJPm: Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: A systematic review. 2020;141:106242.

    Google Scholar 

  52. Zhetpisbayeva I, Kassymbekova F, Sarmuldayeva S, Semenova Y, Glushkova N. Cervical Cancer Prevention in Rural Areas. Ann Glob Health. 2023;89(1):1-15.

  53. Kue J, Zukoski A, Keon KL, Thorburn S. Breast and cervical cancer screening: exploring perceptions and barriers with Hmong women and men in Oregon. Ethn Health Affairs. 2014;19(3):311–27.

    Article  Google Scholar 

  54. Dau H, Vidler M, AboMoslim M, Mutamba B, Nesbitt Z, Deodatha J, Byiringiro SD, Niyotwiringiye C, Mithani N, Nair V. The barriers to cervical cancer screening for urban and rural populations in Rwanda. BMC Global Public Health. 2023;1(1):4.

    Article  Google Scholar 

  55. Olajide NA, Jani BD, Niedzwiedz CL, Johnman C, Robb KA. Awareness of cervical cancer and screening in Benin and Cameroon: analysis of the Demographic and Health Survey, 2017–2018. J Glob Health Rep. 2023;7:e2023045.

  56. Levy AR, Bruen BK, Ku L. Peer reviewed: health care reform and women’s insurance coverage for breast and cervical cancer screening. Prev Chronic Dis. 2012;9:120069.

  57. Sheppard VB, Hurtado-de-Mendoza A, Song M, Hirpa F, Nwabukwu I. The role of knowledge, language, and insurance in endorsement of cancer screening in women of African origin. Preventive medicine reports. 2015;2:517–23.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Managers of DHS for making the dataset available.

Funding

The author did not receive any funding for this study.

Author information

Authors and Affiliations

Authors

Contributions

EAA conceptualized the study, obtained and analyzed the data, SKA wrote the introduction and the results, CDB wrote the discussions, CB wrote the methods, BM wrote the abstract, and AA reviewed the paper. All authors contributed extensively to the work presented in this paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Stanley Kofi Alor.

Ethics declarations

Ethics approval and consent to participate

The 2022 GDHS protocol was approved by the Ghana Health Service Ethics Review Committee and ICF Institutional Review Board. Informed consent was obtained from all adult participants and informed assent from minors. A formal request to use the raw data was made to The DHS Program through their website (https:// dhsprogram. com/ data/ available-datasets. cfm). The study was performed in accordance with relevant regulations and guidelines. Data used in this study were anonymised before use.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anaba, E.A., Alor, S.K., Badzi, C.D. et al. Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey. BMC Cancer 24, 920 (2024). https://doi.org/10.1186/s12885-024-12697-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-024-12697-6

Keywords